对于患有表面基细胞癌的患者,患者决策辅助的有效性:实施前和后的一项研究
Lieke C J van Delft1, Brigitte A B Essers2, Patty J Nelemans3
1Department of Dermatology, Maastricht University Medical Center+, Maastricht, the Netherlands; GROW School for Oncology and Reproduction, Maastricht University, the Netherlands.
Patient education and counseling
|July 24, 2023
概括
对表面基细胞癌 (sBCC) 的患者决策辅助 (PDA) 并没有减少决策冲突,但改善了患者的知识. PDA可以作为sBCC患者的宝贵信息工具.
科学领域:
- 皮肤病学 皮肤病学
- 健康决策的决策过程
- 患者教育 患者教育
背景情况:
- 表面基细胞癌 (sBCC) 是一种常见的皮肤癌.
- 对sBCC的治疗决定对患者来说可能是复杂的.
- 患者对治疗选择和风险的理解对于明智的决策至关重要.
研究的目的:
- 评估患者决策辅助器 (PDA) 对sBCC患者决策冲突和知识的影响.
- 评估PDA是否会在治疗决定后降低决策冲突水平.
- 确定PDA是否增加了患者关于sBCC及其治疗的知识.
主要方法:
- 未来的多中心研究,比较PDA实施前后的患者群体.
- 使用决策冲突尺度 (DCS) 测量决策冲突.
- 通过对治疗选择,sBCC的识别和风险因素的验证问卷评估的知识.
主要成果:
- 控制组和PDA组之间的决策冲突得分没有显著差异 (p=0.828).
- 在PDA组中,平均正确知识得分显著增加 (76.5%至80.5%,p=0.044).
- 大多数PDA组患者 (73.7%) 发现援助有价值.
结论:
- 患者的决策辅助工具并没有显著减少sBCC的决策冲突.
- PDAs有效地增加了患者对表面基底细胞癌的知识.
- 可以利用PDA作为诊断为sBCC的患者的信息资源.
更多相关视频
相关概念视频
Cancer Survival Analysis
386
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
386
Skin Cancer
4.2K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
4.2K


